73 employees
Biomason is a developer of a building materials technology that employs natural microorganisms to grow bio cement in ambient temperatures.
2012
$65M
from 5 investors over 5 rounds
bioMASON Inc raised $65M on February 28, 2022
Investors: Martin Marietta, Novo Holdings, WRVI Capital and 2150
bioMASON Inc raised $1.5M on December 23, 2015
Investors: Acorn Innovestments